Jazz Pharmaceuticals plc Share-based Payment Arrangement, Expense, Tax Benefit
Jazz Pharmaceuticals plc (JAZZ) reported Share-based Payment Arrangement, Expense, Tax Benefit of $19.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-08-03
- Jazz Pharmaceuticals plc share-based payment arrangement, expense, tax benefit for the quarter ending 2026-06-30 was $19.00M, a 54.47% increase year-over-year.
- Jazz Pharmaceuticals plc share-based payment arrangement, expense, tax benefit for the quarter ending 2026-03-31 was $29.80M, a 210.42% increase year-over-year.
- Jazz Pharmaceuticals plc share-based payment arrangement, expense, tax benefit for the quarter ending 2025-12-31 was $13.40M, a 12.63% decline year-over-year.
- Jazz Pharmaceuticals plc share-based payment arrangement, expense, tax benefit for the quarter ending 2025-09-30 was $16.62M, a 36.33% increase year-over-year.
- Jazz Pharmaceuticals plc share-based payment arrangement, expense, tax benefit for fiscal 2025 was $51.81M, a 27.76% increase from fiscal 2024.
- Jazz Pharmaceuticals plc share-based payment arrangement, expense, tax benefit for fiscal 2024 was $40.55M, a 1.34% increase from fiscal 2023.
- Jazz Pharmaceuticals plc share-based payment arrangement, expense, tax benefit for fiscal 2023 was $40.02M, a 2.54% decline from fiscal 2022.
- Jazz Pharmaceuticals plc share-based payment arrangement, expense, tax benefit for fiscal 2022 was $41.06M, a 20.91% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 3 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 12 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $19.00M 10-Q · filed 2026-08-03 | $48.80M 10-Q · filed 2026-08-03 | $62.20M derived: sum of 3 quarters · filed 2026-08-03 | $78.82M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | $29.80M 10-Q · filed 2026-05-05 | $43.20M derived: sum of 2 quarters · filed 2026-05-05 | $59.82M derived: sum of 3 quarters · filed 2026-05-05 | $72.12M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $13.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $30.02M derived: sum of 2 quarters · filed 2026-02-24 | $42.32M derived: sum of 3 quarters · filed 2026-08-03 | $51.81M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $16.62M 10-Q · filed 2025-11-05 | $28.92M derived: sum of 2 quarters · filed 2026-08-03 | $38.41M 10-Q · filed 2025-11-05 | $53.85M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | $12.30M 10-Q · filed 2026-08-03 | $12.26M 10-Q · filed 2025-08-06 | $21.90M 10-Q · filed 2026-08-03 | $21.79M 10-Q · filed 2025-08-06 | $37.23M derived: sum of 3 quarters · filed 2026-08-03 | $49.42M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | $9.60M 10-Q · filed 2026-05-05 | $9.53M 10-Q · filed 2025-05-07 | $24.93M derived: sum of 2 quarters · filed 2026-05-05 | $37.12M derived: sum of 3 quarters · filed 2026-05-05 | $46.75M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $15.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $27.52M derived: sum of 2 quarters · filed 2026-02-24 | $37.15M derived: sum of 3 quarters · filed 2026-02-24 | $40.55M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $12.19M 10-Q · filed 2025-11-05 | $21.82M derived: sum of 2 quarters · filed 2025-11-05 | $25.22M 10-Q · filed 2025-11-05 | $35.70M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $9.63M 10-Q · filed 2025-08-06 | $13.03M 10-Q · filed 2025-08-06 | $23.51M derived: sum of 3 quarters · filed 2026-02-24 | $33.30M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $3.40M 10-Q · filed 2025-05-07 | $13.88M derived: sum of 2 quarters · filed 2026-02-24 | $23.67M derived: sum of 3 quarters · filed 2026-02-24 | $34.80M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $10.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $20.27M derived: sum of 2 quarters · filed 2026-02-24 | $31.40M derived: sum of 3 quarters · filed 2026-02-24 | $40.02M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $9.79M 10-Q · filed 2024-11-07 | $20.91M derived: sum of 2 quarters · filed 2024-11-07 | $29.53M 10-Q · filed 2024-11-07 | $39.96M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $11.12M 10-Q · filed 2024-08-01 | $11.19M 10-Q · filed 2023-08-09 | $19.74M 10-Q · filed 2024-08-01 | $30.17M derived: sum of 3 quarters · filed 2025-02-26 | $40.88M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | $8.62M 10-Q · filed 2024-05-02 | $8.56M 10-Q · filed 2023-05-10 | $19.05M derived: sum of 2 quarters · filed 2025-02-26 | $29.76M derived: sum of 3 quarters · filed 2025-02-26 | $40.78M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $10.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $21.14M derived: sum of 2 quarters · filed 2025-02-26 | $32.16M derived: sum of 3 quarters · filed 2025-02-26 | $41.06M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $10.71M 10-Q · filed 2023-11-08 | $10.67M 10-Q · filed 2022-11-09 | $21.74M derived: sum of 2 quarters · filed 2023-11-08 | $30.63M 10-Q · filed 2023-11-08 | $38.74M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | $11.02M 10-Q · filed 2023-08-09 | $11.14M 10-Q · filed 2022-08-03 | $19.92M 10-Q · filed 2023-08-09 | $19.96M 10-Q · filed 2022-08-03 | $28.03M derived: sum of 3 quarters · filed 2024-02-28 | $38.94M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $8.89M 10-Q · filed 2023-05-10 | $8.82M 10-Q · filed 2022-05-04 | $17.00M derived: sum of 2 quarters · filed 2024-02-28 | $27.92M derived: sum of 3 quarters · filed 2024-02-28 | $36.10M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $8.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $19.03M derived: sum of 2 quarters · filed 2024-02-28 | $27.20M derived: sum of 3 quarters · filed 2024-02-28 | $33.96M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $10.92M 10-Q · filed 2022-11-09 | $10.57M 10-Q · filed 2021-11-09 | $19.09M derived: sum of 2 quarters · filed 2022-11-09 | $25.85M 10-Q · filed 2022-11-09 | $25.53M 10-Q · filed 2021-11-09 | $28.58M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $8.18M 10-Q · filed 2022-08-03 | $8.37M 10-Q · filed 2021-08-03 | $14.93M 10-Q · filed 2022-08-03 | $14.96M 10-Q · filed 2021-08-03 | $17.66M derived: sum of 3 quarters · filed 2023-03-01 | $21.34M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $6.75M 10-Q · filed 2022-05-04 | $6.59M 10-Q · filed 2021-05-04 | $9.48M derived: sum of 2 quarters · filed 2023-03-01 | $13.16M derived: sum of 3 quarters · filed 2023-03-01 | $16.47M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $6.41M derived: sum of 2 quarters · filed 2023-03-01 | $9.72M derived: sum of 3 quarters · filed 2023-03-01 | $12.84M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $3.68M 10-Q · filed 2021-11-09 | $3.44M 10-Q · filed 2020-11-02 | $6.99M derived: sum of 2 quarters · filed 2021-11-09 | $10.11M 10-Q · filed 2021-11-09 | $13.57M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $3.31M 10-Q · filed 2021-08-03 | $2.92M 10-Q · filed 2020-08-04 | $6.43M 10-Q · filed 2021-08-03 | $6.67M 10-Q · filed 2020-08-04 | $9.89M derived: sum of 3 quarters · filed 2022-03-01 | $14.00M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $3.12M 10-Q · filed 2021-05-04 | $3.75M 10-Q · filed 2020-05-05 | $6.59M derived: sum of 2 quarters · filed 2022-03-01 | $10.69M derived: sum of 3 quarters · filed 2022-03-01 | $15.17M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $7.57M derived: sum of 2 quarters · filed 2022-03-01 | $12.04M derived: sum of 3 quarters · filed 2022-03-01 | $15.71M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $4.11M 10-Q · filed 2020-11-02 | $8.58M derived: sum of 2 quarters · filed 2020-11-02 | $12.25M 10-Q · filed 2020-11-02 | $17.41M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | $4.47M 10-Q · filed 2020-08-04 | $8.14M 10-Q · filed 2020-08-04 | $13.30M derived: sum of 3 quarters · filed 2021-02-23 | $16.86M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | $3.67M 10-Q · filed 2020-05-05 | $8.83M derived: sum of 2 quarters · filed 2021-02-23 | $12.38M derived: sum of 3 quarters · filed 2021-02-23 | $17.23M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | $5.16M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $8.72M derived: sum of 2 quarters · filed 2021-02-23 | $13.56M derived: sum of 3 quarters · filed 2021-02-23 | $17.23M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $3.55M 10-Q · filed 2019-11-05 | $8.40M derived: sum of 2 quarters · filed 2019-11-05 | $12.07M 10-Q · filed 2019-11-05 | $10.04M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $4.85M 10-Q · filed 2019-08-06 | $8.51M 10-Q · filed 2019-08-06 | $6.49M derived: sum of 3 quarters · filed 2020-02-25 | $12.84M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $3.67M 10-Q · filed 2019-05-07 | $1.64M derived: sum of 2 quarters · filed 2020-02-25 | $8.00M derived: sum of 3 quarters · filed 2020-02-25 | $17.84M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | -$2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $4.33M derived: sum of 2 quarters · filed 2020-02-25 | $14.17M derived: sum of 3 quarters · filed 2020-02-25 | $21.79M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $6.35M 10-Q · filed 2018-11-06 | $16.19M derived: sum of 2 quarters · filed 2018-11-06 | $23.82M 10-Q · filed 2018-11-06 | $29.50M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $9.84M 10-Q · filed 2018-08-07 | $17.46M 10-Q · filed 2018-08-07 | $23.14M derived: sum of 3 quarters · filed 2019-02-26 | $31.63M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $7.62M 10-Q · filed 2018-05-08 | $13.30M derived: sum of 2 quarters · filed 2019-02-26 | $21.79M derived: sum of 3 quarters · filed 2019-02-26 | $30.71M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $5.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $14.17M derived: sum of 2 quarters · filed 2019-02-26 | $23.09M derived: sum of 3 quarters · filed 2019-02-26 | $30.02M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $8.49M 10-Q · filed 2017-11-07 | $7.25M 10-Q · filed 2016-11-08 | $17.41M derived: sum of 2 quarters · filed 2017-11-07 | $24.34M 10-Q · filed 2017-11-07 | $21.41M 10-Q · filed 2016-11-08 | $24.69M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | $8.92M 10-Q · filed 2017-08-08 | $7.20M 10-Q · filed 2016-08-09 | $15.86M 10-Q · filed 2017-08-08 | $14.16M 10-Q · filed 2016-08-09 | $16.20M derived: sum of 3 quarters · filed 2018-02-27 | $22.86M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $6.93M 10-Q · filed 2017-05-09 | $6.96M 10-Q · filed 2016-05-10 | $7.28M derived: sum of 2 quarters · filed 2018-02-27 | $13.94M derived: sum of 3 quarters · filed 2018-02-27 | $20.85M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | $349.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $7.01M derived: sum of 2 quarters · filed 2018-02-27 | $13.92M derived: sum of 3 quarters · filed 2018-02-27 | $20.07M 10-K · filed 2018-02-27 | $26.61M 10-K · filed 2016-02-23 | |||
| 2015-09-30 | $6.66M 10-Q · filed 2016-11-08 | $13.57M derived: sum of 2 quarters · filed 2016-11-08 | $19.72M 10-Q · filed 2016-11-08 | $18.10M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $6.91M 10-Q · filed 2016-08-09 | $13.06M 10-Q · filed 2016-08-09 | $11.44M derived: sum of 3 quarters · filed 2017-02-28 | $16.91M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $6.15M 10-Q · filed 2016-05-10 | $4.53M derived: sum of 2 quarters · filed 2017-02-28 | $10.00M derived: sum of 3 quarters · filed 2017-02-28 | $15.42M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $3.85M derived: sum of 2 quarters · filed 2017-02-28 | $9.26M derived: sum of 3 quarters · filed 2017-02-28 | $13.55M 10-K · filed 2017-02-28 | $20.80M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $5.47M 10-Q · filed 2015-11-09 | $10.88M derived: sum of 2 quarters · filed 2015-11-09 | $15.17M 10-Q · filed 2015-11-09 | $19.14M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | $5.42M 10-Q · filed 2015-08-05 | $9.70M 10-Q · filed 2015-08-05 | $13.67M derived: sum of 3 quarters · filed 2016-02-23 | $17.18M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $4.29M 10-Q · filed 2015-05-07 | $8.26M derived: sum of 2 quarters · filed 2016-02-23 | $11.76M derived: sum of 3 quarters · filed 2016-02-23 | $15.29M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | $3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $7.47M derived: sum of 2 quarters · filed 2016-02-23 | $11.01M derived: sum of 3 quarters · filed 2016-02-23 | $13.82M 10-K · filed 2016-02-23 | ||||
| 2013-09-30 | $3.50M 10-Q · filed 2014-11-04 | $7.04M derived: sum of 2 quarters · filed 2014-11-04 | $9.85M 10-Q · filed 2014-11-04 | |||||
| 2013-06-30 | $3.54M 10-Q · filed 2014-08-05 | $6.35M 10-Q · filed 2014-08-05 | ||||||
| 2013-03-31 | $2.85M 10-Q · filed 2014-05-08 | |||||||
| 2012-12-31 | $7.50M 10-K · filed 2015-02-24 | |||||||
| 2011-12-31 | $0.00 10-K · filed 2014-02-25 | |||||||
| 2010-12-31 | $0.00 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |